
WuXi Biologics (Cayman)
WXIBF | OTC
$5.94
-$0.21 (-3.41%)
At close: Nov 16, 2026, 1:57 PM ET
$6.00
+$0.06 (+1.01%)
Pre-market:
Nov 16, 2026, 8:05 AM ET
-3.41%
(1D)No price chart data available for 1D timeframe.
Rating
71.1
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #47/1021 (Top 5%)
Key Statistics
Market Data
Market Cap $24.45B
1D Range
5.80 5.99
52W Range
3.90 7.49
Valuation (TTM)
PE 34.90
PB 3.45
EV/EBITDA 16.42
Valuation (NTM)
Forward PE 28.46
Forward PEG 1.08
Price Target $0.00
Cash Flow
FCF Yield 2.7%
SBC Adj. FCF Yield 2.4%
SBC Impact -10.3%
Margins
Gross Margin 47.5%
Operating Margin 32.4%
FCF Margin 18.7%
Growth (CAGR)
Revenue 3Y | 5Y 76.2% |
102.8%
Dil EPS 3Y | 5Y 54.9% |
101.9%
FCF 3Y | 5Y 268.2% |
422.8%
Returns
ROA 7.7%
ROE 10.5%
ROIC 10.6%
Financial Health
Net Cash
¥12.36B ($1.82B)
Current Ratio 3.04
Interest Coverage 74.60
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in Chi...
Sector Healthcare
Industry Biotechnology
Employees 13,252
IPO Date Jan 30, 2018
Website www.wuxibiologics.com
Fiscal Year n/a
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove WXIBF